SCHEMBL7574997

SCHEMBL7574997

O=C(O)C(Nc1ccc(O)c(Cl)c1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.44
CA1 P00915 4/20 0.44
ALDH1A1 P00352 4/20 0.43
MAPT P10636 3/20 0.43
LMNA P02545 1/20 0.43
FPR2 P25090 1/20 0.42
ESR2 Q92731 1/20 0.42
RAB9A P51151 3/20 0.42
GAA P10253 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
EPHX2 P34913 1/20 0.41
HSD17B2 P37059 3/20 0.40
STK10 O94804 1/20 0.40
GSK3B P49841 1/20 0.40
SLK Q9H2G2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPC1 O15118 2/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7584703 0.87 NPC1 (0.53) CA2CA1ALDH1A1MAPTFPR2
SCHEMBL7576130 0.83 NPC1 (0.56) ALDH1A1MAPTLMNARAB9AKDM4E
SCHEMBL7576269 0.83 FPR2 (0.41) CA2CA1MAPTLMNAFPR2
SCHEMBL7584713 0.82 CA1 (0.44) CA2CA1ALDH1A1MAPTLMNA
SCHEMBL1696047 0.80 MDM2 (0.48) CA2CA1ALDH1A1MAPTLMNA
SCHEMBL7598789 0.80 ALDH1A1 (0.62) ALDH1A1MAPTLMNARAB9AGAA
SCHEMBL2639604 0.79 NPC1 (0.54) ALDH1A1MAPTLMNARAB9AKDM4E
SCHEMBL7575006 0.79 FPR2 (0.42) CA2CA1MAPTLMNAFPR2
SCHEMBL7576844 0.79 ALDH1A1 (0.56) ALDH1A1MAPTLMNAFPR2RAB9A
SCHEMBL7573687 0.78 MAOA (0.48) CA2CA1MAPTLMNAFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed